
Irinotecan Suppliers & Bulk Manufacturers
Available Forms: Injection/Infusion Solution
Available Strengths: 100 mg/5 mL, 300 mg/15 mL
Reference Brands: Camptosar® (US & EU)
Category: Oncology Cancer Care
Irinotecan is available in Injection/Infusion Solution and strengths such as 100 mg/5 mL, 300 mg/15 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Irinotecan is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Irinotecan can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Irinotecan is an essential chemotherapy drug used in the treatment of various cancers, including colorectal, ovarian, and lung cancer. As a topoisomerase I inhibitor, it blocks DNA replication in cancer cells, preventing tumor growth. Available in intravenous (IV) solution forms, it is commonly provided in 100 mg/5 mL and 300 mg/15 mL strengths. Marketed under the brand Camptosar® by Pfizer, as well as in generic versions such as Irinotecan Accord and Irinotecan Mylan, it is widely sourced by B2B pharmaceutical wholesalers across the US and EU, ensuring reliable supply, GMP compliance, and competitive pricing for oncology centers.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers